Caption Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Caption Management's VRTX Position: Q2 2026 in Review
Caption Management increased its Vertex Pharmaceuticals (VRTX) stake by 4,600% in Q2 2026, buying an estimated $4.08M and bringing the position to 9,400 shares worth $4.67M. The position accounts for 0.02% of the portfolio, ranked #608.
Caption Management first reported a position in VRTX in Q3 2021 and has held it in 6 quarters since. The position peaked at $12.6M in Q1 2022. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Caption Management held 9,400 shares of Vertex Pharmaceuticals worth $4.67M as of Q2 2026.
- Caption Management bought 9,200 Vertex Pharmaceuticals shares in Q2 2026, an estimated $4.08M.
- Vertex Pharmaceuticals made up 0.02% of Caption Management's portfolio in Q2 2026, its #608 holding.
- Caption Management first reported a position in Vertex Pharmaceuticals in Q3 2021 and has held it in 6 quarters since.
- Caption Management's Vertex Pharmaceuticals position peaked at $12.6M in Q1 2022.
- 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.